Cerebrovascular & Comprehensive Stroke Center Milestones

Awards and Accreditations

2024 Get with the Guidelines
US News - High Performing Hospital emblem
AACN Beacon Award for Excellence
America's Best 100 Stroke Care: 2016 - 2025
  • The ONLY hospital in New York State to be named as one of America's 100 Best HospitalsTM by Healthgrades for stroke care for the past 10 years (2016 - 2025)
  • First Joint Commission (TJC)-certified Comprehensive Stroke Center in Suffolk County (2018, and continuous recertified (2020 - present) — offering end-vascular treatment for stroke, 24-hours a day, 7 days a week.
  • Recipient of Gold Plus Achievement Award from the American Stroke Association for the "Get with the Guidelines" Stroke Program for 14 consecutive years (2010 - 2024), with added distinctions of "Target: Stroke Honor Roll" (2014, 2017), "Target: Stroke Honor Roll-Elite" (2015, 2016, 2018, 2019, 2020, 2023, 2024),"Target: Stroke Honor Roll-Elite Plus" (2017, 2021, 2022), inaugural recipient of "Target: Stroke Advanced Therapy Honor Roll" (2020, 2023, 2024), and recipient of "Target: Type 2 Diabetes Honor Roll" (2021, 2022, 2023, 2024) 
  • Recipient of the Silver Beacon Award of Excellence (2024-2027) from the American Association of Critical-Care Nurses (AACA). This three-year award for our Neurocritical Care Unit (NCCU) recognizes unit caregivers who successfully improve patient outcomes and align practices with AACN's six Healthy Work Environment Standards. Stony Brook is one of only five NCCUs in New York State to receive this award.

Leading the Field

  • Long Island's first and only Mobile Stroke Unit Program, designed to provide specialized, life-saving care to people within the critical moments of stroke before they even get to the hospital.
  • Suffolk County's only Adult and Pediatric Level 1 Trauma Center (the highest level as verified by the American College of Surgeons (ACS)
  • First institution in the country to treat cerebral aneurysm with the Pipeline™ Flex Embolization device in the setting of the COCOA and PUFS clinical research trials
  • First institution on Long Island to utilize Onyx® for arteriovenous malformations and aneurysms
  • First institution on Long Island to utilize the Penumbra System® for clot removal in acute ischemic stroke
  • First to offer intracranial stroke treatment with novel temporary endovascular bypass technology